Index | Nasdaq Biotechnology |
Investment focus | Equity, United States, Health Care |
Fund size | GBP 252 m |
Total expense ratio | 0.40% p.a. |
Replication | Synthetic (Unfunded swap) |
Legal structure | ETF |
Strategy risk | Long-only |
Sustainability | No |
Fund currency | USD |
Currency risk | Currency unhedged |
Volatility 1 year (in GBP) | 18.43% |
Inception/ Listing Date | 6 November 2014 |
Distribution policy | Accumulating |
Distribution frequency | - |
Fund domicile | Ireland |
Fund Provider | Invesco |
Fund Structure | Open-ended Investment Company (OEIC) |
UCITS compliance | Yes |
Administrator | Northern Trust International Fund Administration Services (Ireland) Limited |
Investment Advisor | Invesco Capital Management LLC |
Custodian Bank | Northern Trust Fiduciary Services (Ireland) Limited |
Revision Company | PricewaterhouseCoopers |
Fiscal Year End | 30 November |
Swiss representative | BNP PARIBAS SECURITIES SERVICES, Paris, succursale de Zurich |
Swiss paying agent | BNP Paribas Securities Services, Paris, succursale de Zurich |
Germany | 30% tax rebate |
Switzerland | ESTV Reporting |
Austria | Tax Reporting Fund |
UK | UK Reporting |
Indextype | Total return index |
Swap counterparty | Goldman Sachs|J.P. Morgan|Morgan Stanley |
Collateral manager | |
Securities lending | No |
Securities lending counterparty |
YTD | +6.14% |
1 month | +0.08% |
3 months | -2.16% |
6 months | +5.17% |
1 year | +17.43% |
3 years | +4.29% |
5 years | +28.71% |
Since inception (MAX) | +93.13% |
2023 | -1.50% |
2022 | +0.33% |
2021 | +0.93% |
2020 | +21.82% |
Volatility 1 year | 18.43% |
Volatility 3 years | 23.08% |
Volatility 5 years | 25.42% |
Return per risk 1 year | 0.94 |
Return per risk 3 years | 0.06 |
Return per risk 5 years | 0.20 |
Maximum drawdown 1 year | -10.13% |
Maximum drawdown 3 years | -24.46% |
Maximum drawdown 5 years | -30.71% |
Maximum drawdown since inception | -33.80% |
Listing | Trade Currency | Ticker | Bloomberg / iNAV Bloomberg Code | Reuters RIC / iNAV Reuters | Market Maker |
---|---|---|---|---|---|
gettex | EUR | NBTK | - - | - - | - |
Borsa Italiana | USD | - | SBIO IM SBIOINE | SBIO.MI 0J1KINAV.DE | Commerzbank KCG |
Borsa Italiana | EUR | SBIO | SBIO IM SBIOINE | SBIO.MI 0J1KINAV.DE | Commerzbank KCG |
Euronext Amsterdam | EUR | SBIO | SBIO NA SBIOINE | SBIO.AS 0J1JINAV.DE | Commerzbank KCG |
London Stock Exchange | USD | SBIO | SBIO LN SBIOIN | SBIO.L 0J1KINAV.DE | Commerzbank KCG |
SIX Swiss Exchange | USD | SBIO | SBIO SW SBIOIN | SBIO.S 0J1KINAV.DE | Commerzbank KCG |
XETRA | EUR | NBTK | NBTK GR SBIOINE | NBTKG.DE 0J1JINAV.DE | Commerzbank KCG |
Fund name | Fund Size in m € (AuM) | TER p.a. | Distribution | Replication |
---|---|---|---|---|
iShares Nasdaq US Biotechnology UCITS ETF | 465 | 0.35% p.a. | Accumulating | Sampling |
iShares Nasdaq US Biotechnology UCITS ETF USD (Dist) | 34 | 0.35% p.a. | Distributing | Sampling |